In a regulatory filing Dr Reddy#39;s said, "The audit of our formulations Shreveport plant, Louisiana, USA, by the United States Food and Drug Administration (USFDA) has been completed with zero observations".
Subscribe to:
Post Comments (Atom)
-
Thirteen tier 2 and 3 cities register higher traffic in December than pre-COVID-19 levels.
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
No comments:
Post a Comment